Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
Titel:
Multicenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell Carcinoma
Auteur:
Hurwitz, Michael E. Markowski, Paul Yao, Xiaopan Deshpande, Hari Patel, Jaymin Mortazavi, Amir Donadio, Alessia Stein, Mark N. Kelly, William Kevin Petrylak, Daniel Peter Mehnert, Janice M.